
कृपया अन्य खोज का प्रयास करें
चिन्ह | एक्सचेंज | करेंसी | ||
---|---|---|---|---|
HLUNb | कोपेनहेगेन | DKK | रियल टाइम | |
HLUNa | कोपेनहेगेन | DKK | रियल टाइम | |
0ND5 | लंदन | DKK | रियल टाइम |
H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company’s principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat depression/schizophrenia. It also provides Azilect for treating Parkinson’s disease; Cipralex/Lexapro for depression; Ebixa to treat Alzheimer’s disease; Onfi for Lennox-Gastaut syndrome; Sabril for treating epilepsy; and Xenazine for chorea associated with Huntington’s disease, as well as other products. The company sells its products primarily to distributors of pharmaceuticals, pharmacies, and hospitals. It has a partnership agreement with Verantos to focus on a study to enable real-world evidence in support of migraine therapy; and collaboration with Rgenta Therapeutics, Inc. The company was founded in 1915 and is headquartered in Valby, Denmark.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Lars Soren Rasmussen | 63 | 2013 | Independent Chairman |
Lars Erik Holmqvist | 63 | 2015 | Director |
Jeremy Max Levin | 69 | 2017 | Independent Director |
Jeffrey Berkowitz | 56 | 2018 | Independent Director |
Santiago Arroyo | 62 | 2021 | Independent Director |
Camilla Gram Andersson | 50 | 2022 | Employee Representative Director |
Dorte Clausen | 38 | 2022 | Employee Representative Director |
Hossein Armandi | 60 | 2022 | Employee Representative Director |
Lasse Skibsbye | 39 | 2022 | Employee Representative Director |
Lene Skole-Sorensen | 63 | 2015 | Deputy Chairman |
Dorothea Wenzel | 53 | 2021 | Independent Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है